Until now, programmed cell death ligand 1 (PD-L1) expression, microsatellite instability (MSI), TMB, and circulating tumor cells (CTCs) have been widely investigated as potential predictive biomarkers for ICI efficacy. Here, CD274 is linked to neoplasm.